Log In
Print
BCIQ
Print
Print this Print this
 

Ameluz (BF-200 ALA)

  Manage Alerts
Collapse Summary General Information
Company Biofrontera AG
DescriptionPhotodynamic therapy (PDT) consisting of nanoemulsion BF-200 with 5-aminolevulinic acid (ALA) photosensitizer followed by red light illumination
Molecular Target Not available
Mechanism of ActionPhotodynamic therapy
Therapeutic ModalityMedical Devices: Photodynamic therapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

$1.6M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today